Anglonordic Life Sciences Conference
Anglonordic Life Sciences Conference April 3, 2025 London, UK Simon Kerry, CEO & Cora Griffin, Head of Business Development attending
Entries by oncotron
BIO-Europe Spring
BIO-Europe Spring March 17-19, 2025 Milan, Italy Cora Griffin, Head of Business Development attending
From big pharma to biotech; reflections on the UK life sciences industry amid British Science Week
Curve Perspectives article – Rab Prinjha Rab Prinjha joined Curve Therapeutics in 2024 as Chief R&D Officer, after 25 years at GSK. In this Curve Perspectives article to mark British Science Week, Rab explains why he joined Curve, how Southampton is shaping up as a biotech hub, and the importance of collaboration in the UK […]
How Curve’s Proprietary Microcycle® Discovery Platform is Reinventing Drug Discovery
Curve Perspectives article – Ali Tavassoli With its powerful Microcycle platform technology, Curve Therapeutics is building a pipeline of innovative drugs with a focus on cancer, immunology and inflammation. Our Co-Founder and Chief Scientific Officer, Ali Tavassoli, explains more. Simon Kerry and I co-founded Curve in 2019 with a vision to transform the lives of […]
JP Morgan 43rd Annual Healthcare Conference
JP Morgan 43rd Annual Healthcare Conference 13-16 January 2025 San Francisco, US CEO Simon Kerry and Head of Business Development Cora Griffin attending
2024 a transformational year of progress: A note from the CEO
2024 has been a transformational year for Curve. We kicked off the year with a significant Series A financing, raising £40.5 million from a world class syndicate which includes our existing blue chip investors Advent Life Sciences and Epidarex Capital, alongside new investment from Pfizer Ventures, Columbus Venture Partners and British Patient Capital. The financing […]
London Life Sciences Week
London Life Sciences Week 17-21 November 2024 London, UK CEO Simon Kerry and Head of Business Development Cora Griffin attending
BIO-Europe 2024
BIO-Europe 2024 4-6 November 2024 Stockholm, Sweden CEO Simon Kerry and Head of Business Development Cora Griffin attending
Curve Therapeutics continues to enhance leadership team with appointment of Rab Prinjha as Chief R&D Officer
Southampton, UK, 9 October 2024 – Curve Therapeutics (“Curve” or the “Company”), a private biotechnology company pioneering a revolutionary intracellular screening platform addressing complex and challenging disease targets, today announces the appointment of Rab Prinjha, PhD, as Chief Research and Development (R&D) Officer. This continues Curve’s strong momentum expanding its leadership team following the recent appointments of Andre Hoekema and Cora Griffin, joining as Chair of the Board and Head of Business Development respectively.
Curve Therapeutics further strengthens leadership team with the appointment of Andre Hoekema as new Chair of Board
Curve Therapeutics (“Curve” or the “Company”), a private biotechnology company pioneering a revolutionary intracellular screening platform addressing complex and challenging disease targets, today announces the further strengthening of its leadership team with the appointments of Andre Hoekema as Chair of the Board and Cora Griffin as Head of Business Development.
